^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
HS-10370
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Jiangsu Hansoh Pharma
Drug class:
KRAS G12C inhibitor
Related drugs:
Phase 1/2
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Recruiting
Last update posted :
06/09/2023
Initiation :
06/03/2022
Primary completion :
04/30/2025
Completion :
04/30/2026
KRAS
|
KRAS mutation • KRAS G12C • KRAS G12
|
HS-10370
Share
